Simultaneous quantification of imatinib and CGP74588 in human plasma by liquid chromatography-time of flight mass spectrometry (LC-TOF-MS) - Analytical Methods (RSC Publishing) DOI:10.1039/C5AY02807H
Imatinib Line, Mechanism Of Action, Targeted Therapy, Abl, Pharmaceutical Drug, Enzyme Inhibitor, Philadelphia Chromosome, Acute Lymphoblastic Leukemia, Imatinib, Mechanism Of Action, Targeted Therapy png | PNGWing
Imatinib - an overview | ScienceDirect Topics
Mode of action of imatinib (Gleevec) in CML: Occupation of the tyrosine... | Download Scientific Diagram
What is Gleevec? - Quora
Modern Therapy of Chronic Myeloid Leukemia | IntechOpen
Mode of action of imatinib on BCR-ABL. ADP, adenosine diphosphate; ATP,... | Download Scientific Diagram
Gleevec: Mechanism of Action - YouTube
Imatinib‑induced apoptosis of gastric cancer cells is mediated by endoplasmic reticulum stress
Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events | Arteriosclerosis, Thrombosis, and Vascular Biology
Frontiers | Potential Approaches Versus Approved or Developing Chronic Myeloid Leukemia Therapy
Figure 2, Schematic model for the mechanism of action of Gleevec (imatinib) - Mechanistic Evidence in Evidence-Based Medicine: A Conceptual Framework - NCBI Bookshelf
Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update - Cytotherapy
Mode of action of imatinib. The phosphorylation of a substrate is shown... | Download Scientific Diagram
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. | Australian Medical Student Journal
Imatinib Mesylate — A New Oral Targeted Therapy | NEJM